- stock
- bulk
- Price
Supplier Type
- Manufacturer
- custom synthesis
- Trader
- Reagent
- contract manufacturer
Supplier Region
- Hyderabad(17)
- Gujarat(2)
- Bangalore(1)
- Telangana(3)
- Maharashtra(4)
- Mumbai(3)
- Andhra Pradesh(2)
- Karnataka(1)
- Uttar Pradesh(1)
- Tamil Nadu(1)
Purity
- γ-glutamyl donor substrate
- United States Pharmacopeia (USP) Reference Standard
- serine racemase inhibitor
- ReagentPlus?, 99%
- Novabiochem?
- mol wt 500-4,000
- HCl 98%
- HCl 97%
- for synthesis
- for chiral derivatization, LiChropur?, ≥98.0%
- CRS, European Pharmacopoeia (EP) Reference Standard
- AldrichCPR
- A broad-spectrum protein tyrosine kinase inhibitor.
- 99.86%
- 99.60%
- 99.52%
- 99.50%
- 99.47%
- 99.18%
- 99.00%
- >99.0%(T)
- ≥99.0% (TLC)
- ≥99.0% (T)
- ≥99.0% (HPLC)
- 99.0%
- 99%+
- 99%,HPLC
- 99%
- 98-100%
- 98+
- ≥98.5% (calc. based on dry substance, T)
- 98.00%
- >98.0%(T)(N)
- >98.0%(T)(HPLC)
- >98.0%(T)
- >98.0%(HPLC)(N)
- >98.0%(HPLC)
- >98.0%(GC)(T)
- >98.0%(GC)(N)
- >98.0%(GC)
- ≥98.0% (TLC)
- ≥98.0% (HPLC)
- ≥98.0% (AT)
- 98%+
- ≥98% (HPLC)
- ≥98%
- 98%
- >98%
- 97.78%
- 97.00%
- >97.0%(T)(HPLC)
- >97.0%(HPLC)
- ≥97.0% (KT)
- 97%
- 96.04%
- >96.0%(GC)(T)
- ≥96.0% (HPLC)
- 96%
- 95.81%
- 95.00%
- >95.0%(GC)
- ≥95.0% (HPLC)
- ≥95% (GC)
- 95%
- >95%
- 90 % Above
- 70.00%
- (cryst) Novabiochem?
- &ge
Package
- 0.5mg
- 1mg
- 15mg
- 40mg
- 200MG
- 500MG-F
- 8530188000
- 0Standard Packaging
- 0.1mg
- 5mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 5g
- 8520990005
- 1g
- 2g
- 8530181000
- 5gm
- 10g
- 25g
- 50g
- 100g
- 100gm
- 8520150100
- 8530111000
- 25mL
- 25gm
- 250gm
- 250g
- 8520215000
- 500gm
- 8520210500
- 500g
- 1kg
- 2.5kg
- 5kg
- 10kg
- 25kg
- 8520212000
- 100kg
- 1Gms
- 5Gms
- 25Gms
- 100Gms
- 500Gms
- 0.18
- Kilogram
- 1MT
- 1and gm
- 10Gms
- 18%
N-Boc-Trans-4-Hydroxy-L-Proline Methyl Ester, CAS:74844-91-0 74844-91-0
N-BOC Sarcosine, Grade: Ultra Pure, Purity: 99%,HPLC 13734-36-6
4-amino-3-Hydroxy benzoic acid, 99%, Export Warty Hdpe Drums 2374-03-0
4-Amino-3-hydroxybenzoic acid 2374-03-0







